Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide Biochemotherapy in Metastatic Melanoma
NCT00014092Phase 2Completed
- Sponsor
- Saint Francis Hospital
- Start
- Dec 1999
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, sargramostim, aldesleukin, interferon alfa-2b in melanoma, sponsored by Saint Francis Hospital. Started Dec 1999; status: completed.
02
Drugs
temozolomidesargramostimaldesleukininterferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00014092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014092.